Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Increase (Decrease) in Accrued Interest Receivable, Net

2.8 / 5 stars · 68/120 Roast Me

NIAGEN BIOSCIENCE, INC. Increase (Decrease) in Accrued Interest Receivable, Net

NIAGEN BIOSCIENCE, INC. (NAGE) reported Increase (Decrease) in Accrued Interest Receivable, Net of -$31.82 thousand for the 6-month period ending 2013-06-29, per its 10-Q filed 2013-08-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2013-08-13

  • NIAGEN BIOSCIENCE, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2013-06-29 was -$31.14K.
  • NIAGEN BIOSCIENCE, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2013-03-30 was -$680.00.
Period endIncrease (Decrease) in Accrued Interest Receivable, Net 3 monthIncrease (Decrease) in Accrued Interest Receivable, Net 6 month
2013-06-29-$31.14K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13
-$31.82K
10-Q · filed 2013-08-13
2013-03-30-$680.00
10-Q · filed 2013-05-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87